CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 26.70
-0.46 (-1.69%)
Nov 11, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 13.81 billion as of November 10, 2026. It is the 7,286th most valuable company in the world and the 366th biggest in Hong Kong. Its market cap has decreased by 10.76% in one year.
Market Cap
13.81B
Enterprise Value
12.82B
Revenue
1.47B
Global Rank
Country Rank
#366 Hong Kong
PE Ratio
190.00
ChartMarket Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 13.81B, an increase of 82.36%. That is a compound annual growth rate of 8.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 13.81B | 9.31% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| China Medical System Holdings | 25.28B |
| Sunshine Lake Pharma | 22.21B |
| The United Laboratories International Holdings | 15.42B |
| Grand Pharmaceutical Group | 15.30B |
| Consun Pharmaceutical Group | 13.45B |
| Fujian Haixi Pharmaceuticals | 12.20B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Shandong Xinhua Pharmaceutical Company | 8.46B |